至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Additive amelioration of ALS by co-targeting independent pathogenic mechanisms.

Ann Clin Transl Neurol. 2019-02; 
FrakesAshley E, BraunLyndsey, FerraiuoloLaura, GuttridgeDenis C, KasparBri
Products/Services Used Details Operation
Gene Synthesis … The shRNA construct targeting human SOD1 was generated and obtained as previously described from the Life Technologies design tool.6 The shRNA sequence was cloned into pSilencer 3.1 (Genscript, Piscataway, NJ, USA) under the human H1 promoter and tested for … Get A Quote

摘要

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease in which glia are central mediators of motor neuron (MN) death. Since multiple cell types are involved in disease pathogenesis, the objective of this study was to determine the benefit of co-targeting independent pathogenic mechanisms in a familial ALS mouse model.

关键词